The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The companies will work with investigators to share the results with the scientific community
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Apollo Telehealth has established more than 700 centers, in 7 states
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Subscribe To Our Newsletter & Stay Updated
